Japanese Study Supports EVAR for Ruptured AAA in Octogenarian Patients With Suitable Anatomy
February 18, 2020—Findings from a nationwide, registry-based Japanese study of the impact of endovascular aneurysm repair (EVAR) on the outcomes of octogenarians with ruptured abdominal aortic aneurysms (rAAAs) were published by Tetsuo Yamaguchi, MD, et al in European Journal of Vascular and Endovascular Surgery (EJVES; 2020;59:219–225).
Study of VQI Data Compares Long-term Outcomes of EVAR and Open Repair for Ruptured AAA
January 23, 2020—A study of data from the Vascular Quality Initiative (VQI) registry evaluated the short- and long-term outcomes of endovascular aneurysm repair (EVAR) and open surgical aneurysm repair (OAR) for ruptured infrarenal abdominal aortic aneurysms (rAAAs).
Vascular Medicine Consult Registry Launched for the SVS Vascular Quality Initiative
January 15, 2020—The Society for Vascular Surgery (SVS), the SVS Vascular Quality Initiative (VQI), and the American Heart Association (AHA) announced the introduction of the Vascular Medicine Consult (VMC) registry for the VQI—a collaboration of the SVS Patient Safety Organization (PSO), the Society for Vascular Medicine, and AHA.
Outcomes Compared With Terumo Aortic’s Treovance EVAR Stent Graft for Favorable Versus Hostile Neck Angulation
December 18, 2019—David Murray, MD, et al conducted a study to compare outcomes of patients with favorable neck angulation (FNA) versus hostile neck angulation (HNA) treated with the Treovance stent graft (Terumo Aortic, formerly Bolton Medical).
Outcomes Published From Large Case Series of Complex AAA Treated With Terumo Aortic’s Fenestrated Anaconda Endograft
December 9, 2019—Findings from an assessment of the technical and clinical outcomes of the Fenestrated Anaconda endograft device (Terumo Aortic) in a large international case series were published online ahead of print in Journal of Vascular Surgery (JVS) by Arne de Niet, MD, et al, on behalf of the Fenestrated Anaconda Study Group.
Medtronic Presents 1-Year Valiant Navion and 4-Year ANCHOR Registry Outcomes
November 22, 2019—Medtronic announced the presentation of 1-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and 4-year clinical outcomes from the ANCHOR registry evaluating the company’s Heli-FX EndoAnchor system in patients with hostile neck abdominal aortic aneurysms (AAAs) at the VEITHsymposium held November 19–23 in New York, New York.
Terumo Acquires Aortica Corporation to Further Bolster Its Vascular Graft Portfolio
November 20, 2019—Terumo Corporation announced the acquisition of Aortica Corporation, which developed the AortaFit automated case planning software to match fenestrations on an endograft with unique locations for each of a patient's branch arteries during fenestrated endovascular aneurysm repair (FEVAR) cases.
Centerline Biomedical Launches IOPS Intraoperative Positioning System
November 18, 2019—Centerline Biomedical, Inc., a spinout company from Cleveland Clinic, announced the successful first-in-human clinical use of the company’s IOPS intraoperative positioning system with an intuitive, interactive, color three-dimensional display for minimally invasive vascular repairs.
Analysis From Vascular Quality Initiative Shows Correlation of AAA Size and Outcomes After EVAR
November 6, 2019—The Society for Vascular Surgery announced the publication of findings from a study based on 22,975 patient records in the Vascular Quality Initiative (VQI), showing that abdominal aortic aneurysm (AAA) diameter has important implications for operative and long-term outcomes for patients.
Endologix Responds to FDA Safety Communication on Risk of Type III Endoleaks in AFX EVAR Grafts
October 28, 2019—The FDA announced that it is evaluating new information on the risk of type III endoleak with the AFX endovascular grafts (AFX with Strata, AFX with Duraply, AFX2 [Endologix]) for the treatment of abdominal aortic aneurysms (AAAs).
Medtronic Gains FDA Breakthrough Device Designations for Valiant TAAA and Valiant Navion LSA Systems
October 8, 2019—Medtronic announced the receipt of FDA Breakthrough Device designations for the company’s Valiant thoracoabdominal aortic aneurysm (TAAA) stent graft system and the Valiant Navion left subclavian artery (LSA) branch thoracic stent graft system.
Study Demonstrates Impact of EVAR on Long-Term Renal Function
September 5, 2019—Findings from a study that aimed to define long-term renal decline after elective endovascular aneurysm repair (EVAR) using estimated glomerular filtration rate (eGFR) were published by Edmund R. Charles, BMBS, BMedSci, et al in European Journal of Vascular and Endovascular Surgery (EJVES; 2019;58:328–333).
Endologix Receives IDE Approval for the Nellix Chimney EVAS System
August 8, 2019—Endologix, Inc. announced that it has received investigational device exemption (IDE) approval from the FDA to commence a new pivotal study to evaluate the safety and effectiveness of the company's Nellix chimney endovascular aneurysm sealing (ChEVAS) system for the endovascular treatment of complex abdominal aortic aneurysms (AAAs).
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.